Burcon Announces Chief Financial Officer Transition

Rhea-AI Summary

Burcon NutraScience (OTCQB: BRCNF), a global technology leader in plant-based protein innovation, has announced the appointment of Ms. Alex Varty as Interim Chief Financial Officer, effective August 4, 2025. She succeeds Mr. Robert Peets, who served as CFO since July 2024.

Ms. Varty, who joined Burcon in February 2024, brings significant experience in finance and accounting, including senior roles at KPMG LLP. She is a Chartered Professional Accountant with a Bachelor of Science in Biotechnology/Chartered Professional Accounting from the University of Waterloo. The transition comes as Burcon continues its evolution into a revenue-generating, innovation company.

Positive

• New CFO brings strong financial and biotechnology background
• Company successfully completed a rights offering fundraise in the past year
• Company is transitioning to revenue-generating status

Negative

• Interim CFO appointment indicates temporary leadership in key financial role
• Second CFO change in just over one year

News Market Reaction

-7.95%

1 alert

-7.95% News Effect

On the day this news was published, BRCNF declined 7.95%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Vancouver, British Columbia--(Newsfile Corp. - August 5, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, is pleased to announce that Ms. Alex Varty has been appointed Interim Chief Financial Officer ("CFO") of Burcon effective August 4, 2025. Ms. Varty succeeds Mr. Robert Peets, who has served as CFO on a fractional basis since July 1, 2024, and will continue to support the Company as a consultant. Burcon extends its sincere thanks to Mr. Peets for his contributions and wishes him continued success in his future endeavors.

Kip Underwood, Burcon’s chief executive officer, commented: “On behalf of the entire Burcon team and our board of directors, I would like to thank Robert for his executive leadership and contributions since joining our management team. In the past year, Robert played a crucial role in our successful rights offering fund raise. Alex has been instrumental in our transition to a revenue-generating, innovation company. Her experience and dedication will support us through this commercial phase.”

Ms. Varty joined the Company in February 2024 and has since taken on the Company's financial and accounting responsibilities. She brings years of experience in finance, accounting, and corporate governance, having previously held senior roles in public accounting at KPMG LLP and in industry. Ms. Varty is a Chartered Professional Accountant and holds a Bachelor of Science degree in Biotechnology / Chartered Professional Accounting from the University of Waterloo.

About Burcon NutraScience Corporation

Burcon is a global technology leader in high-performance plant-based proteins for the food and beverage industry. Our commercial ingredients offer superior taste, texture, and functionality-ideal for formulators seeking next-generation protein solutions. Backed by over two decades of innovation, Burcon holds an extensive patent portfolio covering novel proteins derived from pea, canola, soy, hemp, sunflower, and other plant sources. As a key player in the rapidly growing plant-based market, Burcon is committed to sustainability and to creating best-in-class protein solutions that are better for people and the planet. Learn more at www.burcon.ca.

Forward-Looking Information Cautionary Statement

The TSX has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. This press release contains forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. Forward-looking statements or forward-looking information involve risks, uncertainties and other factors that could cause actual results, performances, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements or forward-looking information can be identified by words such as "anticipate," "aim", "intend," "plan," "goal," "project," "estimate," "expect," "believe," "future," "likely," "may," "should," "could," "will" and similar references to future periods. All statements included in this release, other than statements of historical fact, are forward-looking statements. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements or information. Important factors that could cause actual results to differ materially from Burcon's plans and expectations include the implementation of our business model and growth strategies; trends and competition in our industry our future business development, financial condition and results of operations and our ability to obtain financing cost-effectively; potential changes of government regulations, and other risks and factors detailed herein and from time to time in the filings made by Burcon with securities regulators and stock exchanges, including in the section entitled "Risk Factors" in Burcon's annual information form for the year ended March 31, 2025 and its other public filings with Canadian securities regulators on SEDAR+ at www.sedarplus.ca. This list is not exhaustive of the factors that may affect any of the Company's forward-looking statements or information. Any forward-looking statement or information speaks only as of the date on which it was made, and, except as may be required by applicable securities laws, Burcon disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Although Burcon believes the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance, and, accordingly, investors should not rely on such statements.

Industry and Investor Contact
Paul Lam
Director, Investor Relations and Communications
Burcon NutraScience Corporation
490 - 999 West Broadway, Vancouver, BC, V5Z 1K5
Tel (604) 733-0896, Toll-free (888) 408-7960
plam@burcon.ca www.burcon.ca

Media Contact:
Steve Campbell, APR
President
Campbell & Company Public Relations
Tel (604) 888-5267
TECH@CCOM-PR.COM

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/261091

FAQ

Who is the new CFO of Burcon NutraScience (BRCNF)?

Ms. Alex Varty has been appointed as Interim Chief Financial Officer of Burcon NutraScience, effective August 4, 2025. She is a Chartered Professional Accountant with experience at KPMG LLP.

Why did Burcon NutraScience (BRCNF) change its CFO?

The previous CFO, Mr. Robert Peets, who served on a fractional basis since July 2024, is transitioning to a consultant role. The change supports Burcon's evolution into a revenue-generating, innovation company.

What is Alex Varty's background and experience?

Ms. Varty is a Chartered Professional Accountant with a Bachelor of Science in Biotechnology/Accounting from the University of Waterloo. She has held senior roles in public accounting at KPMG LLP and joined Burcon in February 2024.

What recent financial achievements has Burcon NutraScience (BRCNF) accomplished?

Under the previous CFO Robert Peets, Burcon successfully completed a rights offering fundraise, and the company is transitioning to become a revenue-generating, innovation company.